For health care professionals in EUROPE excepted those practicing in France as the following pages are intended to all International health care professionals and are not in compliance with the French Advertising law N°2011-2012 dated 29th December 2011 article 34. Other health care professionals should select their country in the top right corner of the website.
Please note that the following pages are exclusively reserved for health care professionals in countries with applicable health authority product registrations. To the extent this site contains information, reference guides and databases intended for use by licensed medical professionals, such materials are not intended to offer professional medical advice. Prior to use, please consult device labeling for prescriptive information and operating instructions.
This Website is protected by the laws on copyright and by the relevant international conventions. It is strictly forbidden to make copies, whether partial or total and on whichever media without prior approval.
Innova™ is a Self-Expanding Nitinol stent with a peripheral vasculature indication and is designed specifically for Superficial Femoral Artery (SFA) and Proximal Popliteal Artery (PPA) stenting.
Radial strength and flexibility
InnovaTM is designed to combine an excellent flexibility and a high radial strength to optimize the results with tight and calcified lesions and to help supporting the mechanical stress of the SFA and PPA (Proximal Popliteal Arteries).
InnovaTM has one delivery system with dual deployment options : one by rolling the thumbwheel and the other one by grasping the manual pull grip. The stent placement and visibility are facilitated by tantalum markers on the stent and a radiopaque tip.
Boston Scientific Corporation has completed enrollment in the SuperNOVA trial, a global, single arm, prospective, multicenter trial evaluating the long-term (12 month) safety and effectiveness of the Innova™ Self-Expanding Stent System.
Discover Boston Scientific balloon dilatation catheter recommended for the treatment of the Superficial Femoral Artery and Proximal Popliteal Artery lesions.